查找临床试验
已按「系统性硬化症」检索，对应国际通用词 systemic sclerosis
共找到 97 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 00:25，每 5 分钟自动同步正在招募不适用NCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
United States
年龄 不限 – 不限
Sanford Health
正在招募不适用NCT07650565
Tissue Modeling in Systemic Sclerosis Using Induced Pluripotent Stem Cells (iPSCs)
France
年龄 18 Years – 85 Years
University Hospital, Montpellier
正在招募I 期NCT07284797
A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
Australia
年龄 18 Years – 75 Years
Xencor, Inc.
正在招募II 期NCT07047690
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
United States、Switzerland
年龄 18 Years – 不限
Galderma R&D
正在招募II 期NCT06195072
Platform Clinical Study for Conquering Scleroderma
United States
年龄 18 Years – 不限
Scleroderma Research Foundation, Inc.
正在招募不适用NCT06256575
Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis
Canada
年龄 18 Years – 不限
Primus Pharmaceuticals
正在招募I 期 / II 期NCT06434363
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
United States
年龄 18 Years – 不限
M.D. Anderson Cancer Center
正在招募I 期NCT07085104
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
United States、Canada
年龄 18 Years – 74 Years
Allogene Therapeutics
正在招募不适用NCT06732674
Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases
Norway
年龄 18 Years – 不限
Oslo University Hospital
正在招募不适用NCT04334031
Deployment o the Multidisciplinary Prospective Cohort Imminent
France
年龄 18 Years – 不限
University Hospital, Lille
正在招募II 期NCT06619561
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
United States
年龄 18 Years – 不限
Deciphera Pharmaceuticals, LLC
正在招募III 期中国有中心NCT07691970
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
United States、Argentina、Australia、Austria、Belgium 等 12 国
年龄 5 Years – 80 Years
AstraZeneca